Imagin Medical Inc C.IME

Alternate Symbol(s): IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.

CSE:IME - Post by User

Imagin Medical Inc

Bullboard Posts

Comment by Dcowboy31on Nov 03, 2017 1:53pm

112 Views

Post# 26902080

RE:Study date is no "typo" (new 52wk high)

NovaAU10000 wrote: The study is expected to be complete in 3mos but standard procedure requires them to leave the stucy open for 12mos. Also, the doctor must monitor the patients for 12mos. Therefore the 2018 date. No worries people. Standard procedure.

Why would he have to monitor them for 12 months....?

All this technology does is detect the cancer it doesn't cure it lol.

Bullboard Posts

Globex Mining: Unveiling Québec’s hidden gold and lithium treasures